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Abstract
Birth weight is an important factor in newborn survival; both low and high birth weights are associated with adverse
later-life health outcomes. Genome-wide association studies (GWAS) have identified 190 loci associated with maternal or
fetal effects on birth weight. Knowledge of the underlying causal genes is crucial to understand how these loci influence
birth weight and the links between infant and adult morbidity. Numerous monogenic developmental syndromes are
associated with birth weights at the extreme ends of the distribution. Genes implicated in those syndromes may provide
valuable information to prioritize candidate genes at the GWAS loci. We examined the proximity of genes implicated in
developmental disorders (DDs) to birth weight GWAS loci using simulations to test whether they fall disproportionately
close to the GWAS loci. We found birth weight GWAS single nucleotide polymorphisms (SNPs) fall closer to such genes than
expected both when the DD gene is the nearest gene to the birth weight SNP and also when examining all genes within
258 kb of the SNP. This enrichment was driven by genes causing monogenic DDs with dominant modes of inheritance. We
found examples of SNPs in the intron of one gene marking plausible effects via different nearby genes, highlighting the
closest gene to the SNP not necessarily being the functionally relevant gene. This is the first application of this approach to
birth weight, which has helped identify GWAS loci likely to have direct fetal effects on birth weight, which could not
previously be classified as fetal or maternal owing to insufficient statistical power.
Introduction
Weight at birth is an important factor in newborn and infant
survival (1), and it is associated with a higher risk of adverse
adult health outcomes at both the high and low ends of the pop-
ulation distribution (2–4). Variation in birth weight is influenced
by a combination of environmental and genetic factors, and
genome-wide association studies (GWAS) of birth weight have
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implicated 190 genomic loci to date (5–7). The associated variants
at three-quarters of the identified loci where classification is
possible show direct effects of the fetal genotype, a small pro-
portion of which also show maternal effects. The rest represent
single nucleotide polymorphisms (SNPs) having only indirect
effects of the maternal genotype (acting via the intrauterine
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pathways underlying birth weight variation will be crucial to
understanding its links with infant and adult morbidity. How-
ever, causal variants at the identified GWAS loci have not yet
been identified; many of the SNPs that mark the association
signals fall outside coding regions, and it is unclear whether
the functional variant they are tagging exerts its effect via the
nearest gene or elsewhere.
Rare developmental syndromes arising from severe muta-
tions in a single, known gene may provide valuable informa-
tion to help prioritize candidate genes at the GWAS loci (8–10).
Numerous monogenic developmental syndromes include either
extreme fetal overgrowth (e.g. Cantu syndrome caused by muta-
tions in ABCC9 (11) and Clove syndrome caused by mutations
in PIK3CA (12)) or severe fetal growth restriction (e.g. Floating-
Harbor syndrome caused by mutations in SRCAP (13,14) and
Myhre syndrome caused by mutations in SMAD4 (15,16)). The
overlap between genes with monogenic effects on birth weight
and loci associated with birth weight from GWAS has not been
formally examined.
Following a previous GWAS of adult height, Wood et al.
(17) used a curated list of genes associated with rare human
conditions of abnormal skeletal growth to investigate the
identified loci. They hypothesized that common variation in
or near the genes on the list would underlie several of the
GWAS signals and thereby implicate biological pathways of
relevance to normal variation in adult height. They found that
the height GWAS loci were 1.4-fold more likely to fall near to the
curated list of genes than simulated lists of randomly selected
SNPs/indels. For fetal genetic variation underlying birth weight
variation, it is not known whether a similar relationship exists
between monogenic and polygenic loci. If such an overlap exists,
it could help to prioritize candidate genes at these loci and to
understand the biological pathways underlying birth weight. We
tested whether the genes known to cause severe developmental
disorders (DDs) (18) were nearer lead birth weight GWAS SNPs
with evidence of fetal effects, than expected by chance (Fig. 1).
Genes implicated in DDs were chosen because extremes of birth
weight are frequently seen in DDs. To maximize power, we chose
to include all genes implicated in DDs rather than limiting our
analyses solely to DD genes with birth weight recorded as a
feature of the associated disorder because many of the DDs
are extremely rare and lack detailed phenotype information. By
including all DD genes, we would capture those effects on birth
weight which had not been recorded. We found evidence that the
birth weight GWAS SNPs tested fell disproportionately close to
genes that cause severe DDs and that this was driven by disease
genes that act via a dominant mechanism. This approach helps
to highlight potentially causal genes at GWAS loci, underscored
by the fact that, for 24 of the 37 SNPs falling near to DD genes,
the nearest gene to the SNP was not the DD gene.
Results
Method validation
Positive control: height SNPs. There was strong evidence of
enrichment for DD genes being the closest gene to height SNPs
(Tables 1 and 2). Of the 1362 DD genes, 81 were the closest gene
to at least one height SNP (P < 0.0001), and 46 of these genes
act in a dominant manner and 35 are recessive-only (P < 0.0001,
P = 0.0002, respectively). From the 694 height SNPs, 97, 55 and 42
have a DD gene as the nearest gene from the full list of genes,
list of dominant genes and genes with only recessive effects,
respectively (P < 0.0001, P < 0.0001, P = 0.0011). These results
mirror those of Wood et al (17) which found strong evidence
of enrichment for genes underlying monogenic syndromes of
abnormal skeletal growth. In the window analysis, dominant DD
genes show consistent strong evidence for enrichment within
the 19, 94, 138 and 258 kb windows (48 genes, P < 0.0001; 84
genes, P < 0.0001; 103 genes, P < 0.0001; 136 genes, P < 0.0001,
respectively). There is only weak evidence that recessive-only
genes are enriched within these windows (46 genes, P = 0.0013;
88 genes, P = 0.017; 124 genes, P = 0.0099; 185 genes, P = 0.010,
respectively). The number of height SNPs with recessive-only
DD genes within each window shows no evidence of enrichment
(51 SNPs, P = 0.051; 94 SNPs, P = 1.00; 128 SNPs, P = 1.00; 180 SNPs,
P = 1.0, respectively).
Negative controls: eye color and random SNPs. As expected, SNPs
associated with eye color show no evidence of enrichment for
proximity to DD genes (all P > 0.05; Tables 3 and 4). The lack of
enrichment in these SNPs suggests that the method is working
as expected, however, the small number of SNPs associated with
eye color could contribute to the lack of evidence for enrich-
ment. We therefore also randomly selected 156 SNPs, which also
showed no evidence for enrichment in either the nearest gene
analysis or windows analysis (Tables 5 and 6).
Birth weight SNPs
Nearest gene. The full list of genes linked to rare monogenic
DDs contained 1362 autosomal genes. Of these, 20 were the
closest gene for at least one lead SNP from the GWAS of birth
weight. The P-value for enrichment compared with the empirical
distribution of matching SNPs was P = 0.0002 (Table 7). Of the 156
birth weight SNPs, the nearest gene for 22 SNPs was in the full list
of DD genes (P = 0.0036) (Table 8). When we split the list of genes
into those that cause disease via either a dominant (n = 475)
or recessive (n = 887) mode of inheritance only, 14 dominant
genes were the nearest gene of at least one birth weight SNP
(P < 0.0001) compared with six recessive-only genes (P = 0.17).
The nearest gene for 15 of the birth weight SNPs was in the list of
dominant DD genes (P < 0.0001), and by comparison, the nearest
gene for only 7 of the birth weight SNPs was a DD gene with
recessive-only effects (P = 0.55).
Gene windows. Of the full list of DD genes, 22, 48, 57 and 82
genes fell within 19, 94, 138 and 258 kb of at least one birth weight
SNP, respectively (P = 0.0021; P = 0.0002; P = 0.0015; P = 0.001,
respectively). Of the birth weight SNPs, 24, 45, 50 and 67 SNPs
had at least one gene from the full gene list within 19, 94, 138
and 258 kb, respectively (P = 0.005; P = 0.0012; P = 0.011; P = 0.011).
Genes in which rare mutations cause dominant DDs showed
strong evidence of enrichment within the gene windows analy-
sis with 13, 25, 27 and 36 genes, respectively, in the 19, 94, 138 and
258 kb windows (P < 0.0001; P < 0.0001; P < 0.0001; P = 0.0003). Of
the birth weight SNPs, 14, 26, 27 and 37 had at least one dominant
disease gene within each of the windows (P = 0.0008; P < 0.0001;
P = 0.0013; P = 0.0013). There was little evidence that genes in
which rare mutations cause only recessive disease showed any
enrichment in the gene window analyses: a total of 9, 23, 30 and
46 (P = 0.12; P = 0.025; P = 0.017; P = 0.010) genes were within each
window of at least 1 birth weight SNP, while a total of 10, 24, 29
and 42 (P = 0.42; P = 0.25; P = 0.34; P = 0.19) birth weight SNPs had at
least one recessive-only gene within each window, respectively.
Results from sensitivity analysis excluding ‘Unclassified’
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Figure 1. Flow chart showing each of the steps in the enrichment analysis.
Table 1. Number of DD genes which are the nearest gene, or within the corresponding window, of 694 height SNPs, and the corresponding
empirical P-value
Gene list (number of genes) Nearest 19 kb 94 kb 138 kb 258 kb
N P N P N P N P N P
All genes (1362) 81 <1.00E-4 94 <1.00E-4 172 4.50E-03 227 2.00E-04 321 4.60E-03
Dominant (475) 46 <1.00E-4 48 <1.00E-4 84 <1.00E-4 103 <1.00E-4 136 <1.00E-4
Recessive (936) 46 <1.00E-4 57 3.00E-04 105 1.15E-02 141 7.00E-03 208 9.80E-03
Recessive excluding
dominant (887)
35 2.00E-04 46 1.30E-03 88 1.74E-02 124 9.90E-03 185 1.00E-02
Table 2. Number of height SNPs (total NSNPs = 694) for which a DD gene is the nearest gene, or for which a DD gene is within the corresponding
window, and the corresponding empirical P-value
Gene list (number of genes) Nearest 19 kb 94 kb 138 kb 258 kb
N P N P N P N P N P
All genes (1362) 97 <1.00E-4 103 <1.00E-4 177 2.69E-01 228 1.05E-01 287 9.62E-01
Dominant (475) 55 <1.00E-4 55 <1.00E-4 98 <1.00E-4 125 <1.00E-4 163 <1.00E-4
Recessive (936) 56 <1.00E-4 65 2.00E-04 115 8.83E-01 148 9.10E-01 202 1.00E+00
Recessive excluding
dominant (887)
42 1.10E-03 51 5.12E-02 94 9.98E-01 128 9.97E-01 180 1.00E+00
Table 3. Number of DD genes which are the nearest gene, or within the corresponding window, of 16 eye color SNPs, and the corresponding
empirical P-value
Gene list (number of genes) Nearest 19 kb 94 kb 138 kb 258 kb
N P N P N P N P N P
All genes (1362) 3 9.69E-02 3 1.00E-01 3 3.56E-01 3 4.62E-01 3 6.27E-01
Dominant (475) 1 3.81E-01 1 3.59E-01 1 5.36E-01 1 6.00E-01 1 7.08E-01
Recessive (936) 2 1.52E-01 2 1.68E-01 2 4.26E-01 2 4.99E-01 2 6.37E-01
Recessive excluding
dominant (887)
2 1.33E-01 2 1.43E-01 2 3.95E-01 2 4.71E-01 2 6.10E-01
Material, Tables S1 and S2), where evidence of enrichment
was driven by genes with dominant modes of inheritance
(all P < 0.05). There was little evidence of enrichment among
genes with recessive-only effects (all P > 0.05). (Supplementary
Material, Tables S3 and S4).
Discussion
This is the first study to investigate the overlap between birth
weight GWAS signals and genes known to cause rare DDs. We
found that common lead SNPs from GWAS which are associated
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Table 4. Number of eye color SNPs (total NSNPs = 16) for which a DD gene is the nearest gene, or for which a DD gene is within the corresponding
window, and the corresponding empirical P-value
Gene list (number
of genes)
Nearest 19 kb 94 kb 138 kb 258 kb
N P N P N P N P N P
All genes (1362) 3 1.47E-01 3 1.28E-01 3 4.21E-01 3 5.50E-01 3 7.77E-01
Dominant (475) 1 4.44E-01 1 4.05E-01 1 6.00E-01 1 6.72E-01 1 8.19E-01




2 1.81E-01 2 1.79E-01 2 4.63E-01 2 5.60E-01 2 7.52E-01




Nearest 19 kb 94 kb 138 kb 258 kb
N P N P N P N P N P
All genes (1362) 7 2.83E-01 5 6.13E-01 13 2.50E-01 25 4.43E-02 47 1.09E-02
Dominant (475) 3 3.28E-01 3 3.26E-01 3 5.58E-01 5 3.23E-01 10 1.37E-01




4 3.70E-01 2 8.46E-01 10 1.68E-01 20 1.45E-02 37 1.40E-03
Table 6. Number of randomly selected SNPs (N = 156 SNPs) for which a DD gene is the nearest gene, or for which a DD gene is within the
corresponding window, and the corresponding empirical P-value
Gene list (number
of genes)
Nearest 19 kb 94 kb 138 kb 258 kb
N P N P N P N P N P
All genes (1362) 7 9.44E-01 5 9.62E-01 14 8.87E-01 24 4.50E-01 35 5.40E-01
Dominant (475) 3 8.68E-01 3 6.94E-01 3 9.72E-01 5 9.53E-01 10 9.31E-01




4 9.01E-01 2 9.82E-01 11 6.36E-01 19 1.74E-01 28 1.97E-01
Table 7. Number of DD genes which are the nearest gene, or within the corresponding window, of 156 birth weight SNPs annotated as either
‘Fetal Only’, ‘Maternal and Fetal’ or ‘Unclassified’, and the corresponding empirical P-value
Gene list (number of
genes)
Nearest 19 kb 94 kb 138 kb 258 kb
Ngenes P Ngenes P Ngenes P Ngenes P Ngenes P
All genes (1362) 20 2.00E-04 22 2.10E-03 48 2.00E-04 57 1.50E-03 82 1.00E-03
Dominant (475) 14 <1.00E-4 13 <1.00E-4 25 <1.00E-4 27 <1.00E-4 36 3.00E-04
Recessive (936) 10 1.90E-02 13 1.90E-02 27 9.70E-03 35 7.50E-03 51 5.90E-03
Recessive excluding
dominant (887)
6 1.68E-01 9 1.15E-01 23 2.48E-02 30 1.67E-02 46 1.02E-02
effects, fall disproportionately closer to such genes than to ran-
domly selected similar genes. This enrichment for associations
was driven by DD genes with dominant modes of inheritance
(Table 9), and the pattern was seen both for the nearest gene
analysis and for all window sizes in the gene window analyses.
We validated our method using height SNPs as positive controls
which have previously shown enrichment for proximity to genes
associated with rare human conditions of abnormal skeletal
growth. Negative controls using random SNPs as well as those
robustly associated with eye color show that these associations
are unlikely to represent spurious associations.
The interpretation of GWAS loci and the genes and pathways
impacted by them for complex traits such as birth weight is less
straightforward than that of molecular phenotypes such as urate
levels (23). Rare monogenic variants that cause severe disease
are unlikely to underlie the associations with common SNPs that
are identified in GWAS (24). Rather, the lead SNPs are far more
likely to tag functional variants of a similar frequency. Genes
that are causally linked with any phenotype may harbor a spec-
trum of genetic variants from rare with severe consequences
(such as complete loss of gene function) to common with mild
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Table 8. Number of birth weight SNPs (total NSNPs = 156) for which a DD gene is the nearest gene, or for which a DD gene is within the
corresponding window, and the corresponding empirical P-value. Birth weight SNPs included are all those classified as classified as ‘Fetal
Only’, ‘Maternal and Fetal’ or ‘Unclassified’ in the GWAS of birth weight (5)
Gene list (number of
genes)
Nearest 19 kb 94 kb 138 kb 258 kb
NSNPs P NSNPs P NSNPs P NSNPs P NSNPs P
All genes (1362) 22 3.60E-03 24 5.00E-03 45 1.20E-03 50 1.09E-02 67 1.12E-02
Dominant (475) 15 <1.00E-04 14 8.00E-04 26 <1.00E-04 27 1.30E-03 37 1.30E-03
Recessive (936) 12 8.37E-02 15 5.53E-02 29 6.65E-02 25 7.91E-02 48 4.42E-02
Recessive excluding
dominant (887)
7 5.47E-01 10 4.18E-01 24 2.49E-01 29 3.35E-01 42 1.85E-01
Figure 2. Histogram of the distance from birth weight SNPs to DD genes within
258 kb of the SNP.
support this hypothesis and show that the genes implicated in
rare developmental syndromes can help to prioritize candidate
causal genes at birth weight loci.
Of the 37 birth weight SNPs with DD genes within the largest
258 kb window, this gene is the nearest one for just 13. A
histogram of the distance from these SNPs to the DD gene is
shown in Figure 2. While a DD gene is unlikely to be the relevant
functional gene for every birth weight SNP, this result nonethe-
less highlights the fact that the nearest gene to the SNP is not
necessarily the best candidate for functionally relevant genes.
Our analysis has also helped to categorize GWAS SNPs that were
previously unclassified with respect to maternal or fetal activity
and to prioritize likely candidate genes. For example, high birth
weight is a feature of Noonan syndrome, which can be caused by
missense mutations in the RIT1 gene (25); one of the birth weight
SNPs, ‘Unclassified’ in the recent birth weight GWAS, lies within
the gene boundaries of RIT1, suggesting that the SNP is acting
through the fetal genome.
Examples of DD genes whose associated syndromes include
low or high birth weight, and which are nearby but not the
nearest gene to the birth weight SNP, are CDKN1C and GNAS.
CDKN1C is implicated in syndromes associated with intrauter-
ine growth restriction (IUGR) (IMAGE syndrome) (26) and over-
growth (Beckwith-Wiedemann syndrome) (27); one of the birth
weight SNPs is located 47 146 bp from this gene within an intron
of KCNQ1, which is not linked to DDs. Beckwith-Wiedemann
syndrome can be caused by disorders of methylation affecting
imprinted genes within chromosome 11p15.5 containing IGF2
and CDKN1C, both of which appeared in our analyses (Fig. 3).
GNAS has also been implicated in fetal growth, with mutations
in the paternally inherited copy of the GNAS gene shown to lead
to severe IUGR (28) and loss of methylation leading to increased
fetal growth (29). Rare mutations in this gene are also linked
with low birth weight in the DECIPHER database (30) (https://de
cipher.sanger.ac.uk/gene/GNAS#overview/clinical-info), but the
closest birth weight SNP to GNAS is 142 178 bp away, within the
NPEPL1 gene (Fig. 3). These findings support the hypothesis that
the nearest gene to a SNP identified via GWAS may not always
be the biologically relevant gene (31). Syndromes resulting in
large changes in birth weight associated with both of these DD
genes also feature disorders of imprinting. Imprinted genes have
previously been found to be enriched for birth weight associa-
tions (5), but so far, no parent-of-origin specific associations have
been identified at individual loci. Our approach highlights these
genes as potential candidates for identifying imprinting effects
affecting birth weight within the normal range.
Candidate genes highlighted by our analyses can also point
toward relevant biological pathways. For example, they include
three genes that are linked by IGF-1 receptor signaling (PIK3R1,
IGF1R and IGF2). Two of these genes (PIK3R1 and IGF1R) have
one and two birth weight lead SNPs within the boundaries of
the genes, respectively, while the third gene (IGF2) is 31 481 bp
from the nearest birth weight lead SNP. DDs caused by variation
in each of these genes are all characterized by severe effects
on fetal growth. Mutations in PIK3R are associated with the
SHORT syndrome which is characterized by IUGR (32–34), and
mutations causing dysregulation of IGF1R can also result in
IUGR (35). The IGF2 gene is implicated in syndromes associated
with fetal under-growth (Silver-Russell syndrome) or over-
growth (Beckwith-Wiedemann syndrome) (36). Furthermore,
genes in the sonic hedgehog pathway have been implicated
in the regulation of IGF-1 receptor signalling (37). Genes from
this pathway, such as PTCH1 and GLI2, appear in our DD gene
list, but only PTCH1 appears in proximity to a birth weight locus
in any of our analyses. Rare mutations in PTCH1 are associated
with high birth weight in the DECIPHER database, and lower
levels of PTCH1 expression in preeclamptic placenta samples
has been demonstrated, with strong associations between
expression levels and birth weight (37). Enrichment for SNP
associations with birth weight in pathways linked to these
genes has previously been demonstrated (5), but our approach
highlights individual genes within the pathway which may be
particularly relevant to variation in birth weight.
A pathway which was not specifically highlighted in the
recent GWAS of birth weight but has come up in our analysis is
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Table 9. Dominant DD genes falling near to birth weight SNPs in each of our nearest gene or gene window analyses. Columns 5–9 indicate the





SNPs SNP classifications Nearest 19 kb 94 kb 138 kb 258 kb
CCND2 Dominant rs76895963 Fetal and
Maternal_-_Same
Direction
1 1 1 1 1
JAG1 Dominant rs6040076 Unclassified 1 1 1 1 1
PIK3R1 Dominant/recessive rs28365970 Unclassified 1 1 1 1 1
PTCH1 Dominant/recessive rs28457693 Fetal Only 1 1 1 1 1
PTH1R Dominant rs2168443 Fetal and
Maternal_-_Same
Direction
1 1 1 1 1
RIT1 Dominant rs670523 Unclassified 1 1 1 1 1
RORA Dominant rs339969 Fetal and
Maternal_-_Same
Direction
1 1 1 1 1
SPRED1 Dominant rs75844534 Fetal and
Maternal_-_Opposite
Directions
1 1 1 1 1
STAT1 Dominant/recessive rs2280235 Unclassified 1 1 1 1 1
WT1 Dominant rs5030317 Unclassified 1 1 1 1 1
IGF2 Dominant rs11042596 Fetal Only 1 1 1 1
PDE10A Dominant rs2934844 Unclassified 1 1 1 1
MAFB Dominant rs1012167 Fetal Only 1 1
IGF1R Dominant/recessive rs11630479;
rs7402983
Unclassified; Fetal Only 2 2 2 2 2
NR2F2 Dominant rs55958435;
rs138715366
Unclassified 1 1 1 1
CAMK2B Dominant rs2908279 Fetal Only; Unclassified 1 2 2 2
CDKN1C Dominant rs234864 Fetal Only 1 1 1
CNOT3 Dominant rs255773 Unclassified 1 1 1
DLG4 Dominant rs222857 Fetal Only 1 1 1
EDNRB Dominant rs9318511 Unclassified 1 1 1
FGFR1 Dominant rs34036147 Fetal Only 1 1 1
HIST1H1E Dominant rs9379832 Unclassified 1 1 1
HIST1H4C Dominant rs9379832 Unclassified 1 1 1




SLC2A1 Dominant rs12401656 Fetal Only 1 1 1
P4HB Dominant rs9912553;
rs73354194
Unclassified; Fetal Only 1 1 2
GJC2 Dominant/recessive rs708122 Unclassified 1 1




ACVR1 Dominant rs56188432 Fetal Only 1
CHD3 Dominant rs78378222 Unclassified 1
GNAS Dominant rs6026449 Fetal Only 1
KAT6A Dominant rs13266210 Fetal Only 1
NF1 Dominant rs7223535 Unclassified 1
NOTCH1 Dominant rs28505901 Fetal Only 1
PHF21A Dominant rs10437653 Unclassified 1




mutations in JAG1 and NOTCH2, includes failure to thrive (38)
within its phenotypic spectrum. While it is not certain whether
the birth weight associated SNP near JAG1 acts primarily via
fetal or maternal mechanisms, a reduced expression of JAG1 in
placentas from pregnancies complicated with preeclampsia has
been observed (39). Although no association was seen between
JAG1 levels and birth weight, preeclampsia is itself associated
with reduced birth weight. Other genes in the Notch pathway,
NOTCH1, NOTCH2, DLL3 and DLL4, were also included in our
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Figure 3. Regions surrounding the CDKN1C and GNAS genes showing the location of the genes and the nearby birth weight SNP. Colors represent different functional
annotations and numbers in square brackets indicate additional transcripts.
our analyses, NOTCH1, in the 258 kb gene windows analysis,
whose expression level has not previously been linked with birth
weight.
A large number of birth weight loci overlap with loci known
to be associated with height. It is perhaps not surprising that
several of the DD genes highlighted by our analysis are known
to be associated with short stature, such as IGF1R, IGF2, RIT1 and
NF1.
In the present study, we have described a method for combin-
ing information from common and rare disease genetics to help
prioritize candidate genes through which GWAS loci may act.
We were limited by several factors. First, the list of monogenic
genes we used was clinically curated as part of the Deciphering
Developmental Disorders Study (18) and we included any genes
implicated in DDs, some of which are well known to cause
extremes of birth weight while others do not have birth weight
recorded as a feature of the associated disorder. The inclusion
of genes without effects on birth weight could reduce the power
of the analysis to detect associations owing to the inclusion of
irrelevant genes. We nonetheless chose to include these genes
owing to the extreme rarity of many of the disorders, and thus
the limited availability of detailed phenotypes. Had we excluded
all genes that did not have birth weight recorded as a feature of
the associated disorder, we would likely have excluded genes
with effects on birth weight, that were simply not recorded
due to incomplete phenotyping, which would similarly reduce
power. Second, the list of birth weight loci also included those
categorized as ‘Unclassified’, some of which are likely to act
solely through maternal pathways. Accurate classification of
these loci would also increase the power to detect enrichment,
though the results of our sensitivity analysis where these loci
were excluded, while less powered, were consistent with the
main analysis. Third, while we performed negative control
analysis using SNPs known to influence eye color, only 16 eye
color-associated SNPs were available. Eye color was chosen as a
control trait because it is unlikely to be associated with DDs, but
for future application of the method, a control trait with a larger
number of associated SNPs would be beneficial.
In summary, we have described a newly developed method
and software package for testing GWAS loci for the enrichment
for proximity to genes implicated in monogenic disorders and
have demonstrated an enrichment in birth weight GWAS loci
with fetal effects for proximity to genes where rare mutations
are known to cause DDs. This method could help prioritize
candidate variants from other GWAS to help better understand
the mechanisms underlying their phenotypic effect.
Materials and Methods
Birth weight SNPs
We selected the lead SNP at each of the 190 genomic loci (P < 6.6
× 10−9 and r2 < 0.1) from the latest GWAS of birth weight (5).
Where a locus was known to have different lead SNPs from the
maternal GWAS of offspring birth weight versus the GWAS of
own birth weight (‘fetal GWAS’), we selected the lead SNP from
the fetal GWAS. In that study, the 190 loci had been classified
into categories according to the likely origin of their effects on
birth weight (Supplementary Material, Table S5): ‘Fetal only’ (62
SNPs); ‘Maternal only’ (31 SNPs); ‘Fetal and Maternal’ (35 SNPs)
and ‘Unclassified’ (62 SNPs). SNPs are unclassified if the 95%
confidence intervals for independent maternal and fetal effect
estimates overlap, and at least one overlaps zero (5). Since we
were interested in investigating loci with the direct fetal effects
on birth weight, we excluded the loci classified as ‘Maternal
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excluded from our analyses owing to the difficulty in classifying
X-chromosome genes as dominant or recessive. The resulting
list of lead SNPs used in our analysis included 156 SNPs.
Positive control: height SNPs
Growth abnormalities and extreme variation in height are a core
feature of many DDs, and height GWAS SNPs have previously
been shown to be enriched for genes known to be involved in
growth (17). As a positive control, we tested whether our method
showed evidence of enrichment for the height associated SNPs
identified by Wood et al. (17). Of the 697 identified by Wood
et al., we used the 694 SNPs appearing in our list of UK Biobank
Haplotype Reference Consortium (HRC) imputed SNPs (detailed
later) (Supplementary Material, Table S6).
Negative controls: eye color and random SNPs
To further test the validity of our method, we performed nega-
tive control analyses where we would not expect to see strong
evidence of enrichment for proximity to DD genes. First, we
reasoned that SNPs associated with eye color would not be
expected to fall closer to DD genes than would be expected by
chance, so we tested enrichment for proximity to DD genes of
16 SNPs associated with eye color at P < 5 × 10−8 (19) to use as
a negative control analysis (Supplementary Material, Table S7).
Second, owing to the limited number of SNPs associated with
eye color, we further selected 156 SNPs randomly from our list of
HRC SNPs (see in the following text).
Gene lists
A clinician-curated list of protein-coding genes definitively
linked to monogenic disorders (20) was downloaded from
https://www.ebi.ac.uk/gene2phenotype/ on 18 July 2018. Genes
on the X-chromosome were excluded. Genes were separated into
groups based on the mode of inheritance of their associated DDs
(dominant, recessive or both). The list of DD genes can be found
in Supplementary Material, Table S8.
Enrichment analysis
We aimed to test whether our 156 selected lead SNPs, marking
common fetal variant effects on birth weight, fall near to genes
in which rare variants cause DDs (that may include high or low
birth weight) more often than would be expected by chance,
i.e. we tested for ‘enrichment’ of proximity to developmental
syndrome genes in our list of GWAS SNPs. For each enrichment
analysis, we used the 17 073 342 SNPs with minor allele fre-
quency (MAF) > = 0.1% included in the UK Biobank HRC imputed
dataset (release v3 March 2018) as a reference (21). From this list
of reference SNPs, we selected 10 000 lists of SNPs, which were
matched to the lead SNPs from GWAS of birth weight based on
the matching criteria listed in the following text. These lists of
matching SNPs were used to create an empirical distribution,
described later, from which we calculated empirical P-values for
the corresponding list of birth weight loci (Fig. 1). We used two
sets of matching criteria: (1) the distance to the nearest gene and
(2) the number of genes within a given distance. We repeated
these analyses splitting the list of DD genes into those with
dominant modes of inheritance and those with recessive modes
of inheritance. These criteria are described in more detail in the
following sections, and the code required to run the analysis has
been packaged and can be downloaded from https://github.com/
rnbeaumont/DD_gene_enrichment.
Nearest gene. Each of the 156 birth weight lead SNPs was anno-
tated with its nearest gene and the distance to that gene. The
criteria for selecting 10 000 lists of matched SNPs for the nearest
gene analysis were: MAF for the matching SNP between 0.9 and
1.1× the MAF of the index SNP; and distance to the nearest gene
of the matching SNP within ±10% of the distance of the index
SNP to the nearest gene. For each of the 10 000 lists of matched
SNPs, we calculated the number of SNPs for which their nearest
gene appeared in the lists of DD genes. We also calculated the
number of DD genes that appeared in the nearest gene list for the
matched SNPs. These were used as our empirical distributions.
We then calculated the number of nearest genes for the birth
weight loci which appeared in the DD genes lists and vice versa.
Gene windows. We annotated each birth weight SNP with the
number of genes 19, 94, 138 and 256 kb either side of the SNP.
To select window sizes objectively, we chose the mean, median,
lower quartile and upper quartile of the distances from lead
birth weight SNPs to eight placenta eQTL genes (22) from the
Warrington et al. GWAS of birth weight (5) as these represent bio-
logically plausible distances between functional units, although
our results are unlikely to be sensitive to the exact window sizes
used. The criteria for selecting the 10 000 lists of matched SNPs
for the gene window analyses were: the MAF of the matching
SNP within 0.9–1.1× the MAF of the lead birth weight SNP; and
number of genes within the window matching that of the lead
birth weight SNP. For each list of the lists of matching SNPs, we
calculated the number of SNPs for which one or more of the
genes within the relevant window were in the list of DD genes
and the number of those genes which appear within the relevant
distance of at least one matched SNP. The empirical P-values for
the number of birth weight SNPs for which at least one of the
genes within the window appear in the list of DD genes and vice
versa using the empirical distributions.
Sensitivity analysis
These analyses were repeated excluding birth weight SNPs cat-
egorized as ‘Unclassified’ (5) as a sensitivity analysis, as that
category could include SNPs with maternal effects.
Supplementary Material
Supplementary Material is available at HMG online.
Data Availability
Data used in these analyses is publicly available: birth weight
summary statistics can be downloaded from http://egg-co
nsortium.org/; the list of HRC SNPs can be downloaded from
http://www.haplotype-reference-consortium.org/site; access
information for UK Biobank can be found at https://www.u
kbiobank.ac.uk/; a list of DDD genes can be downloaded from
https://www.ebi.ac.uk/gene2phenotype/ (accessed 18th July
2018). Positive control data was downloaded from https://po
rtals.broadinstitute.org/collaboration/giant/index.php/GIANT_
consortium_data_files (accessed 14 October 2020), and negative
control data was downloaded from https://www.ebi.ac.uk/gwa
s/efotraits/EFO_0009764 (accessed 2 October 2020). Code to run
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